Share Ownership
Basic Information
As of September 30, 2025
| Total number of authorized shares: | Total number of shares outstanding: | Number of shareholders |
|---|---|---|
| 320,000,000 | 129,686,308 | 26,873 |
Ownership Profile
(As of September 30, 2025)
Major shareholders
(As of September 30, 2025)
| Name of Shareholder | Number of Shares (thousands) | Shareholding Ratio (%) |
|---|---|---|
| MEDIPAL HOLDINGS CORPORATION | 29,131 | 23.83 |
| Future Brain Co., Ltd. | 8,711 | 7.12 |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 8,247 | 6.74 |
| The Nomura Trust and Banking Co., Ltd. | 6,298 | 5.15 |
| Kissei Pharmaceutical Co., Ltd. | 4,918 | 4.02 |
| Custody Bank of Japan, Ltd. (Trust Account) | 4,356 | 3.56 |
| Mochida Pharmaceutical Co., Ltd. | 2,200 | 1.80 |
| THE NOMURA TRUST AND BANKING CO., LTD. AS THE TRUSTEE OF REPURCHASE AGREEMENT MOTHER FUND （常任代理人 シティバンク、エヌ・エイ東京支店） |
1,937 | 1.58 |
| Employee Shareholding Association of JCR Pharmaceuticals Co., Ltd. | 1,421 | 1.16 |
| 吉村 光司 | 1,200 | 0.98 |
Number of Shareholders
(As of March 31 of each year)
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 20,953 | 19,200 | 17,524 | 22,888 | 23,046 |